本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

12.45
-1.7700-12.45%
盘后12.450.00000.00%16:10 EDT
成交量:588.15万
成交额:7,386.15万
市值:19.15亿
市盈率:-31.75
高:13.94
开:13.83
低:12.00
收:14.22
52周最高:20.76
52周最低:6.68
股本:1.54亿
流通股本:1.17亿
量比:2.61
换手率:5.01%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
净资产收益率:-27.82%
总资产收益率:-6.79%
市净率:8.75
市盈率(LYR):-31.75

数据加载中...

2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

重要事件披露

Form 8-K - Current report